Notably, experimental groups exhibited significantly decreased chest HRCT scores and TNF‐α level compared to control groups (Figures 1 and 4), indicating that pirfenidone therapy outperformed corticosteroid treatment in the reduction of inflammation and COVID‐19–induced ILAs. This evidence concerns the gene TNF and COVID-19.